Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Matic

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|July 5, 2022
Microsporidial myositis, keratitis and hypercalcaemia in a cystic fibrosis lung transplant recipientAnna Louise Watson, Marko Matic, Thomas Robertson, et al.
The International Journal of Biochemistry & Cell Biology|December 26, 2006
Pregnane X receptor: promiscuous regulator of detoxification pathwaysMarko Matic, Andre Mahns, Maria Tsoli, et al.
The International Journal of Biochemistry & Cell Biology|January 12, 2010
The alternatively spliced murine pregnane X receptor isoform, mPXR(delta171-211) exhibits a repressive actionMarko Matic, Anthony P Corradin, Maria Tsoli, et al.
Nuclear Receptor Signaling|May 28, 2009
A novel approach to investigate the subcellular distribution of nuclear receptors in vivoMarko Matic, Sarah Nakhel, Anne M Lehnert, et al.
International Journal of Pharmaceutics|September 4, 2021
Continuous mixing technology: Validation of a DEM modelPeter Toson, Pankaj Doshi, Marko Matic, et al.
Plos One|June 20, 2019
Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha ActionMarko Matic, Galyna Bryzgalova, Hui Gao, et al.
Plos One|March 2, 2013
Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha actionMarko Matic, Galyna Bryzgalova, Hui Gao, et al.
Plos One|January 14, 2014
aP2-Cre-mediated inactivation of estrogen receptor alpha causes hydrometraPer Antonson, Marko Matic, Neil Portwood, et al.
Blood Neoplasia|June 24, 2025
Outcomes for high-risk defining events in follicular lymphoma following frontline immunochemotherapyJoshua W D Tobin, Venkata A Chikatamarla, Marko Matic, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|July 5, 2022
Microsporidial myositis, keratitis and hypercalcaemia in a cystic fibrosis lung transplant recipientAnna Louise Watson, Marko Matic, Thomas Robertson, et al.
The International Journal of Biochemistry & Cell Biology|December 26, 2006
Pregnane X receptor: promiscuous regulator of detoxification pathwaysMarko Matic, Andre Mahns, Maria Tsoli, et al.
The International Journal of Biochemistry & Cell Biology|January 12, 2010
The alternatively spliced murine pregnane X receptor isoform, mPXR(delta171-211) exhibits a repressive actionMarko Matic, Anthony P Corradin, Maria Tsoli, et al.
Nuclear Receptor Signaling|May 28, 2009
A novel approach to investigate the subcellular distribution of nuclear receptors in vivoMarko Matic, Sarah Nakhel, Anne M Lehnert, et al.
International Journal of Pharmaceutics|September 4, 2021
Continuous mixing technology: Validation of a DEM modelPeter Toson, Pankaj Doshi, Marko Matic, et al.
Plos One|June 20, 2019
Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha ActionMarko Matic, Galyna Bryzgalova, Hui Gao, et al.
Plos One|March 2, 2013
Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha actionMarko Matic, Galyna Bryzgalova, Hui Gao, et al.
Plos One|January 14, 2014
aP2-Cre-mediated inactivation of estrogen receptor alpha causes hydrometraPer Antonson, Marko Matic, Neil Portwood, et al.
Blood Neoplasia|June 24, 2025
Outcomes for high-risk defining events in follicular lymphoma following frontline immunochemotherapyJoshua W D Tobin, Venkata A Chikatamarla, Marko Matic, et al.
Pageof 1